Compounds > tetrachloroisophthalonitrile
Page last updated: 2024-08-21

tetrachloroisophthalonitrile and niraparib

tetrachloroisophthalonitrile has been researched along with niraparib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adam, V; Audeh, W; Balmaña, J; Cameron, DA; Colleoni, M; Ellard, SL; Erban, J; Goldstein, LJ; Goulioti, T; Honkoop, AH; Ignatiadis, M; Jen, KY; Johannsson, OT; Juan-Fita, MJ; Kaufman, B; Láng, I; Litière, S; Macpherson, IRJ; Mailliez, A; Manso, L; Musolino, A; Poncet, C; Razis, E; Trédan, O; Tryfonidis, K; Turner, NC; Tutt, AN; Vuylsteke, P; Zoppoli, G1

Other Studies

1 other study(ies) available for tetrachloroisophthalonitrile and niraparib

ArticleYear
Niraparib for Advanced Breast Cancer with Germline
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 10-15, Volume: 27, Issue:20

    Topics: BCG Vaccine; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Female; Germ Cells; Germ-Line Mutation; Humans; Indazoles; Nitriles; Piperidines

2021